The degradation of chondrogenic pellets using cocultures of synovial fibroblasts and U937 cells

Biomaterials

Volumn 35, Issue 4, 2014, Pages 1185-1191

  Blasioli, Dominick J ^a   Matthews, Gloria L ^b   Kaplan, David L ^a  

^a Tufts University   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

Arthritis; Cartilage tissue engineering; Fibroblast; Macrophage; Modeling

Indexed keywords

ARTHRITIS; CARTILAGE TISSUE ENGINEERING; CONDITIONED MEDIUM; DEGRADATIVE ENZYMES; GLYCOSAMINOGLYCANS; HIGH THROUGHPUT SCREENING; JOINT SPACE NARROWING; SYNOVIAL INFLAMMATION;

CARTILAGE; CELL CULTURE; FIBROBLASTS; MACROPHAGES; MODELS; PELLETIZING; PHOTODEGRADATION; STEM CELLS; TISSUE ENGINEERING;

JOINTS (ANATOMY);

AGGRECAN; COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMELYSIN;

ARTICLE; CARTILAGE DEGENERATION; CELL INTERACTION; CELL STRAIN U937; CHONDROGENIC STEM CELL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE MODEL; ENZYME SYNTHESIS; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KNEE OSTEOARTHRITIS; MACROPHAGE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; SYNOVIAL FLUID; SYNOVIOCYTE; SYNOVITIS; TISSUE ENGINEERING;

ARTHRITIS; CARTILAGE TISSUE ENGINEERING; FIBROBLAST; MACROPHAGE; MODELING;

CELLS, CULTURED; COCULTURE TECHNIQUES; FIBROBLASTS; GLYCOSAMINOGLYCANS; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 1; OSTEOARTHRITIS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TISSUE ENGINEERING; U937 CELLS;

EID: 84888428185     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.050     Document Type: Article

References (48)

1. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049.
2. Lawrence R.C., Felson D.T., Helmick C.G., Arnold L.M., Choi H., Deyo R.A., et al. Arthritis Rheum 2008, 58(1):26-35.
3. Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000, 43:1905-1915.
4. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartilage 2008, 16:137-162.
5. Dieppe P., Brandt K.D., Lohmander S., Felson D.T. Detecting and measuring disease modification in osteoarthritis. The need for standardized methodology. JRheumatol 1995, 22:201-203.
6. Osteoarthritic disorders 1995, American Academy of Orthopaedic Surgeons Symposium, Rosemont, Illinois. K.E. Kuettner, V.M. Goldberg (Eds.).
7. Appleton C.T., McErlain D.D., Pitelka V., Schwartz N., Bernier S.M., Henry J.L., et al. Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis. Arthritis Res Ther 2007, 9:R13.
8. Roberts M.J., Adams S.B., Patel N.A., Stamper D.L., Westmore M.S., Martin S.D., et al. Anew approach for assessing early osteoarthritis in the rat. Anal Bioanal Chem 2003, 377:1003-1006.
9. Jimenez P.A., Glasson S.S., Trubetskoy O.V., Haimes H.B. Spontaneous osteoarthritis in Dunkin Hartley guinea pigs: histologic, radiologic, and biochemical changes. Lab Anim Sci 1997, 47:598-601.
10. Akhtar N., Rasheed Z., Ramamurthy S., Anbazhagan A.N., Voss F.R., Haqqi T.M. MicroRNA-27b regulates the expression of MMP-13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010, 62:1361-1371.
11. Sun L., Wang X., Kaplan D.L. A3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis. Biomaterials 2011, 32:5581-5589.
12. Haywood L., McWilliams D.F., Pearson C.I., Gill S.E., Ganesan A., Wilson D., et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003, 48:2173-2177.
13. Kelly M., Kolb M., Bonniaud P., Gauldie J. Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des 2003, 9:39-49.
14. Liu X., Li J., Zhang J. STAT3-decoy ODN inhibits cytokine autocrine of murine tumor cells. Cell Mol Immunol 2007, 4:309-313.
15. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
16. Kirsch T. Cell-cell and cell-matrix interactions during development and pathogenesis. Curr Opin Orthop 2006, 17:387-389.
17. Rosengren S., Boyle D.L., Firestein G.S. Acquisition, culture, and phenotyping of synovial fibroblasts. Methods Mol Med 2007, 135:365-375.
18. Penick K.J., Solchaga L.A., Welter J.F. High-throughput aggregate culture system to assess the chondrogenic potential of mesenchymal stem cells. Biotechniques 2005, 39:687-691.
19. Chen V., Croft D., Purkis P., Kramer I.M. Co-culture of synovial fibroblasts and differentiated U937 cells is sufficient for high interleukin-6 but not interleukin-1b or tumour necrosis factor-a release. Br J Rheumatol 1998, 37:148-156.
20. Kaneko S., Satoh T., Chiba J., Ju C., Inoue K., Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000, 6:71-79.
21. Koch A.E., Kunkel S.L., Burrows J.C., Evanoff H.L., Haines G.K., Pope R.M., et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. JImmunol 1991, 147:2187-2195.
22. Stankovic A., Slavic V., Stamenkovic B., Kamenov B., Bojanovic M., Mitrovic D.R. Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokines in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity. Bratisl Lek Listy 2009, 110:641-646.
23. Koch A.E., Kunkel S.L., Harlow L.A., Johnson B., Evanoff H.L., Haines G.K., et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. JClin Invest 1992, 90:772-779.
24. Koch A.E., Kunkel S.L., Harlow L.A., Mazarakis D.D., Haines G.K., Burdick M.D., et al. Macrophage inflammatory protein-1α. JClin Invest 1994, 93:921-928.
25. + T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999, 11:553-559.
26. Volin M.V., Shah M.R., Tokuhira M., Haines G.K., Woods J.M., Koch A.E. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 1998, 89:44-53.
27. Lee S.S., Joo Y.S., Kim W.U., Min D.J., Min J.K., Park S.H., et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2001, 19:321-324.
28. Koch A.E., Harlow L.A., Haines G.K., Unemori E.N., Wong W.L., Pope R.M., et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. JImmunol 1994, 152:4149-4156.
29. Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K., et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000, 59:455-461.
30. Ribbens C., Andre B., Kaye O., Kaiser M.J., Bonnet V., Jaspar J.M., et al. Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology 2000, 39:1357-1365.
31. Farndale R.W., Buttle D.J., Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883:173-177.
32. Freemont A.J., Hampson V., Tilman R., Goupille P., Taiwo Y., Hoyland J.A. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 1997, 56:542-549.
33. Aigner T., Zien A., Gehrsitz A., Gebhard P.M., McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001, 44:2777-2789.
34. Goldring M.B., Goldring S.R. Osteoarthritis. JCell Physiol 2007, 213:626-634.
35. Eid K., Thornhill T.S., Glowacki J. Chondrocyte gene expression in osteoarthritis: correlation with disease severity. JOrthop Res 2006, 24:1062-1068.
36. Lorenz H., Wenz W., Ivancic M., Steck E., Richter W. Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther 2005, 7:R156-R165.
37. Pagura S.M.C., Thomas S.G., Woodhouse L.J., Ezzat die S., Marks P. Circulating and synovial levels of IGF-I, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to men. JOrthop Res 2005, 23:397-405.
38. Okamoto H., Yamamura M., Morita Y., Harada S., Makino H., Ota Z. The synovial expression and serum levels of Interleukin-6, Interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum 1997, 40:1096-1105.
39. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976, 17:565-577.
40. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980, 26:171-176.
41. Koeffler H.P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 1983, 62:709-772.
42. Fleischer J., Soeth E., Reiling N., Grage-Griebenow E., Flad H.D., Ernst M. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology 1996, 89:592-598.
43. Lyon C.A., Johnson J.L., Williams H., Sala-Newby G.B., George S.J. Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 2009, 29:195-201.
44. Agarwal S.K., Lee D.M., Kiener H.P., Brenner M.B. Coexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes. Arthritis Rheum 2008, 58:1044-1054.
45. Scott B.B., Weisbrot L.M., Greenwood J.D., Bogoch E.R., Paige C.J., Keystone E.C. Rheumatoid arthritis synovial fibroblast and U937 macrophage/monocyte cell line interaction in cartilage degradation. Arthritis Rheum 1997, 40:490-498.
46. DiBenedetto P., Chen F., Yu Q., DiMicco M., Matthews G. Generation of osteoarthritis-like cytokine profiles using an invitro coculture model. Poster session presented at: World Congress on Osteoarthritis 2008 Sep 18-21, Rome, Italy.
47. Shahdadfar A., Fronsdal K., Haug T., Reinholt F.P., Brinchmann J.E. Invitro expansion of human mesenchymal stem cells:choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005, 23:1357-1366.
48. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998, 4:415-428.